2025 Regular Session • Oregon Legislature
HB2536: Relating to step therapy for metastatic cancer treatment.
Legislative Summary
The Act bans health benefit plans from using step therapy for certain cancer drugs and treatments. (Flesch Readability Score: 63.6). Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/13/2025
First reading. Referred to Speaker's desk.
House of Representatives
1/17/2025
Referred to Behavioral Health and Health Care.
House of Representatives
2/11/2025
Public Hearing held.
House of Representatives
Status Information
Current Status
Introduced(1/13/2025)
Chamber
House of Representatives
Committee
Behavioral Health and Health Care(House of Representatives)
Sponsors
Democrat: 3
Republican: 1
Primary Sponsor
Dacia Grayber
Democrat